Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Pharmaceutical Joint Venture
Kali recently announced is partnership in a Joint Venture, to combine its resources and expertise with those of Puration, Inc. (PURA) and Nouveau Life Pharmaceuticals, Inc. (NOUV) to together attract partnerships with major pharmaceutical firms for pharmaceutical developments. With both Puration and Nouveau operations in the North Texas region, Kali will also relocate its primary operations to the North Texas region.
KALY has entered into discussions with Puration, Inc. (USOTC: PURA) ("PU\RA") regarding PURA's possible acquisition of KALY's CBD confection assets.
The next paragraph is very interesting...
"The company has also entered into discussions with a yet undisclosed third-party about the possible sale of KALY's agricultural CBD extraction business."
This is NOUV...
Time to shine, lets hear about it.
Dallas, TX -- November 8, 2019 -- InvestorsHub NewsWire -- Puration, Inc. (USOTC: PURA) today announced a closing date of November 14, 2019 has been set to finalize the acquisition in Germany previously announced under a letter of intent (LOI). The acquisition scheduled to close next Thursday is intended to establish a bottling capacity in Europe for PURA’s CBD beverages.
New York, NY -- November 14, 2019 -- InvestorsHub NewsWire -- via www.nextbigticker.com -- Puration, Inc. (PURA) received a BUY recommendation today from American Bulls (americanbulls.com/PURA). PURA has been trading steadily in the $0.05 range for several weeks following a run to over $0.09. Now PURA looks ready to run again with the potential to blow past the recent $0.09 high and possibly deliver a 600%. Goldman Small Cap Research has rated PURA as a speculative BUY and set a $0.35 PPS Target. PURA has a 52-week high of $0.25.
PURA continues to grow its CBD beverage sales in addition to taking steps to accelerate growth even further. PURA has announced acquisitions under letter of intent intended to expand the companies bottling capacity into Europe and South America. PURA is working through its partner Nouveau (NOUV) to expand cannabis beverage sales into Canada.
Lmfao, "The Verges" sponsored by, The Ihub Investigators, lol. My goodness, Will it ever end.
PURA Savior THC rollout news.
Quote:
The CEO of PURA, Brian Shibley, currently serves as the interim CEO of NOUV while the company is being restructured to accommodate its new cannabis business focus. NOUV's primary focus is cannabis cultivation both in the U.S. and Canada. With a presence in Canada, NOUV will also serve as PURA's first foot in the door to establish distribution for THC Savor in Canada. NOUV has already tackled the licensing process in Canada to be permitted to produce and sell THC Savor. NOUV is also working to establish a bottling relationship for the production of THC Savor.
The CEO of PURA, Brian Shibley, currently serves as the interim CEO of NOUV while the company is being restructured to accommodate its new cannabis business focus. NOUV's primary focus is cannabis cultivation both in the U.S. and Canada. With a presence in Canada, NOUV will also serve as PURA's first foot in the door to establish distribution for THC Savor in Canada. NOUV has already tackled the licensing process in Canada to be permitted to produce and sell THC Savor. NOUV is also working to establish a bottling relationship for the production of THC Savor.
Right...
Funny, "just like PURA"? Lmfao, whatever... By the way have you seen the latest?
https://finance.yahoo.com/news/pura-puration-makes-bid-acquire-144305227.html
Were going to Germany, big time beer haven...
Guess you didn't understand the PR. Its in Canada...HUMMM!!!
Need to hear the annoucement of our CBD beer today. Can't wait, put it out already. This is gonna be good. Go PURA/NOUV
PURA - Puration Canadian THC Beverage Rollout Coming Soon
Source: InvestorsHub NewsWire
DALLAS, TX -- October 30, 2019 -- InvestorsHub NewsWire -- Puration, Inc. (PURA) reminds investors today that the company will rollout plans for its THC Savor beverage in Canada tomorrow, Thursday, October 31, 2019. With Canada legalizing cannabis infused beverages this month, PURA is moving forward with its already designed THC Savor beverage. PURA has already designed a THC infused beverage named THC Savor, and with its Nouveau (NOUV) partner that already has a presence in Canada, PURA has a foot in the door, but tune-in tomorrow to hear more.
PURA realized $1 million in revenue last year in 2018 and then reported another $1 million in revenue in just the first six months of 2019. PURA management has set a $4 million revenue target for year-end 2019. With PURA’s growing number of new distribution agreements in strategic markets, a recent analyst projection has PURA reaching $8 million in revenue in 2020.
For more information on Puration, visit http://www.purationinc.com
Disclaimer/Safe Harbor:
This news release contains forward-looking statements within the meaning of the Securities Litigation Reform Act. The statements reflect the Company's current views with respect to future events that involve risks and uncertainties. Among others, these risks include the expectation that any of the companies mentioned herein will achieve significant sales, the failure to meet schedule or performance requirements of the companies' contracts, the companies' liquidity position, the companies' ability to obtain new contracts, the emergence of competitors with greater financial resources and the impact of competitive pricing. In the light of these uncertainties, the forward-looking events referred to in this release might not occur. These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.
Contact:
Puration, Inc.
Brian Shibley,
info@aciconglomerated.com
(800) 861-1350
Like what I been seeing today. Kaly is getting busy...
http://www.globenewswire.com/news-release/2019/10/30/1937870/0/en/KALY-Kali-Extracts-Entertains-50-Million-Cannabis-Biopharmaceutical-Technology-Acquisition-Valuation.html
Agree, this moves on a dime.
Think you better read into it some more. There's a few farms growing hemp in the area.
Nice artical, in relation. No mention of Kaly, but farm size, its in the ball park.
https://www.recordonline.com/news/20190721/orange-county-farmers-investing-in-cbd-hemp
Yes it is, better buy more farms...lol
KALY Consumer Cannabis Extract Business Reports Growing Revenue Bolstering Its Long Term Biopharmaceutical Strategy
Source: InvestorsHub NewsWire
KALY Consumer Cannabis Extract Business Reports Growing Revenue Bolstering Its Long Term Biopharmaceutical Strategy
Dallas, TX -- October 1, 2019 -- InvestorsHub NewsWire -- Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (USOTC: KALY) (“KALY”) today highlighted the progress of Puration, Inc. (USOTC: PURA) reporting today a new European distribution agreement worth $4 million in potential revenue annually. “What’s good for PURA, is good for KALY,” said KALY CEO Frederick Ferri. PURA has the only licenses of KALY’s US Patented Cannabis Extraction Process for infusing cannabis and hemp extracts into beverages. KALY licensed the process as part of its consumer cannabis extraction business. KALY generates revenue from the direct sale of CBD infused candies under the brand name Hemp4mula and by licensing its extraction process to companies such as PURA. KALY also generates revenue in its consumer cannabis extraction business through the extracting CBD for hemp farming operations. KALY has recently announced hemp farming CBD extraction contracts worth a potential $15 million in revenue. KALY’s consumer cannabis extraction business continues to grow supporting the company’s much larger long-term opportunity, its Cannabis Extract Biopharmaceutical Strategy.
The company has schedule a presentation for next week on Monday, October 7, 2019 to communicate its latest Cannabis Extract Biopharmaceutical developments. The last Cannabis Extract Biopharmaceutical developments update was issued over one month ago. The company has made some substantial strides forward since that time and looks forward to sharing the progress with shareholders.
The update next week will include the latest information on the company’s CBD formulation for treating symptoms associated with Chronic Obstructive Pulmonary Disease (COPD) and other similar respiratory conditions. The formulation for the treatment of symptoms associated with COPD and other similar respiratory conditions has been derived from the company’s patented cannabis extraction process. In conjunction with the research already conducted and the next phase of research now moving forward, KALY recently filed for a new patent application specifically on its formulation for symptoms associated with COPD and other similar respiratory conditions. KALY also filed for a trademark on the name RespRx as the brand name for its CBD formulation to treat the symptoms associated with COPD and other similar respiratory conditions. The market for COPD treatment is anticipated to reach $14 billion by 2025.
In the fourth quarter of last year, 2018, KALY acquired NCMB. In NCMB’s four years of operations, the company has established a leading position in the development of plant-derived cannabinoid therapeutics through a proven drug discovery and patented development process. The resulting intellectual property portfolio and the established regulatory and manufacturing expertise have created a significant opportunity. KALY now has a deep pipeline of cannabinoid product candidates including four distinct compounds listed here:
Chronic Obstructive Pulmonary Disease (COPD) - The market for COPD treatment is anticipated to reach $14 billion by 2025;
Type 2 Diabetes - The market for Type 2 Diabetes is expected to be a $64 billion market by 2026;
Cancer Pain Management - The overall pain management treatment market is anticipated to reach $83 billion by 2024, and
Epilepsy - The market for epilepsy treatment is anticipated to reach $9 billion by 2022.
To learn more about the company visit https://www.kali-extracts.com/
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), and as such, may involve risks and uncertainties. These forward looking statements relate to, amongst other things, current expectation of the business environment in which the company operates, potential future performance, projections of future performance and the perceived opportunities in the market. The company's actual performance, results and achievements may differ materially from the expressed or implied in such forward-looking statements as a result of a wide range of factors.
CONTACT:
Frederick Ferri
ir@kali-extracts.com
(214) 210-0459
Yfos
Very nice buying going on today. Good sign.
ALYI recently announced a partnership with Nouveau (USOTC: NOUV) to develop a prototype car body material from hemp fiber. ALYI recently confirmed plans to extend its current electric motorcycle manufacturing initiative in Africa - targeting an overall $300 million project opportunity - with the subsequent production of electric delivery vehicles. ALYI’s electric delivery vehicle plans call for a vehicle produced from hemp fiber utilizing a hemp battery. NOUV is a new hemp cultivation company with a strategic focus on developing innovative industrial uses for hemp. NOUV is already working with ALYI to provide material for ALYI’s hemp battery developments. NOUV also works with Kali-Extracts (USOTC: KALY) toward the development of proprietary cultivars. NOUV is a spinoff from Puration, Inc. (USOTC: PURA).
PURA and NOUV Announce Cannabis Cultivation Business Update To Include Latest On Planned Dividend and KALY Extraction Partnership
GlobeNewswireSeptember 26, 2019, 5:58 PM UTC
DALLAS, Sept. 26, 2019 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- Puration, Inc. (PURA) (“PURA”) and Nouveau, Inc. (aka Nouveau Life Pharmaceuticals) (NOUV) (“NOUV”) today announced a Cannabis Cultivation Business Update scheduled to be published tomorrow, September 27, 2019.
The update tomorrow is part of a series of PURA corporate releases scheduled for this week following PURA’s CBD beverage industry survey results and corresponding analyst research update published last week in conjunction with PURA’s pre-marketing initiative for its new CBD infused beer, coffee and tea. Management plans to include in the announcements this week the latest news on the progress toward issuing the previously announced dividend of NOUV stock to PURA shareholders. The update will also include an overall update on NOUV’s cannabis cultivation business.
PURA owns the sole license of Kali-Extracts (KALY) U.S. Patented Cannabis Extraction Process which is utilized in the production of PURA’s infused beverages. Separately KALY has entered into an extraction contract with NOUV. The KALY business relationship with PURA and KALY will be included in the update tomorrow.
PURA and NOUV Announce Cannabis Cultivation Business Update To Include Latest On Planned Dividend and KALY Extraction Partnership
GlobeNewswireSeptember 26, 2019, 5:58 PM UTC
DALLAS, Sept. 26, 2019 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- Puration, Inc. (PURA) (“PURA”) and Nouveau, Inc. (aka Nouveau Life Pharmaceuticals) (NOUV) (“NOUV”) today announced a Cannabis Cultivation Business Update scheduled to be published tomorrow, September 27, 2019.
The update tomorrow is part of a series of PURA corporate releases scheduled for this week following PURA’s CBD beverage industry survey results and corresponding analyst research update published last week in conjunction with PURA’s pre-marketing initiative for its new CBD infused beer, coffee and tea. Management plans to include in the announcements this week the latest news on the progress toward issuing the previously announced dividend of NOUV stock to PURA shareholders. The update will also include an overall update on NOUV’s cannabis cultivation business.
PURA owns the sole license of Kali-Extracts (KALY) U.S. Patented Cannabis Extraction Process which is utilized in the production of PURA’s infused beverages. Separately KALY has entered into an extraction contract with NOUV. The KALY business relationship with PURA and KALY will be included in the update tomorrow.
Huge volume yesterday and today, somethings brewing imo.
NOUV is the silent storm waiting to come ashore. This company supports all its partners. Imo the biggest asset.
10 million shares sold in one clip? Wow something is comming imo. Boooowhaa
Very nice volume comming in... Why? Something in the grapevine?
Sure don't see any timber, all I see is timber growing in the up direction. News comming hang tight people.
Absolutely, its comming very soon. Remember, were not only doing business in Texas. Were Alison in Canada and NY, were as its legal.
Heading towards a 20% gain, hold for greater profits. Long and strong. Big news comming.
Flippers trying to manipulate here. Hold tight, buy, buy, buy. Don't let them back in.
Management plans to include in the announcements next week the latest news on the progress toward issuing the previously announced dividend of Nouveau (USOTC: NOUV) stock to PURA
Whatever you say bud. Long and strong here.
Ready, heading, next step up breaks .10s imo
Very nice steps being formed here. Great sign on the charts.
Right...lmao
So your flipping here? The truth comes out. Glty
Lmfao, here we go with this BS again. Give it up call. Get in while you can.
Looking at .10s. Smack it boys and girls. See new heights after .10s.
Oh can't for get to mention ALYI...lol
Our partners PURA is kicking ass, looks like it will break .10 today. PURA, Kaly make good, its all good for NOUV. Expect,to see movement here shortly. Imo